Association of Plasma Pentraxin-3 Level with Lipid Levels and Cardiovascular Risk Factors in People with No History of Lipid-Lowering Medication: the Dong-gu Study-Reference-Cited by-同舟云学术

Association of Plasma Pentraxin-3 Level with Lipid Levels and Cardiovascular Risk Factors in People with No History of Lipid-Lowering Medication: the Dong-gu Study

Published:2019-08-01 Issue:8 Volume:26 Page:738-745
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Lee Ran¹,Ahn Hye-Ran²,Shin Min-Ho¹,Kim Hee-Nam¹,Lee Young-Hoon³,Choi Seong-Woo⁴,Kweon Sun-Seog¹⁵

Affiliation:

1. Department of Preventive Medicine, Chonnam National University Medical School

2. Department of Nursing, Nambu University

3. Department of Preventive Medicine & Institute of Wonkwang Medical Science, Wonkwang University College of Medicine

4. Department of Preventive Medicine, Chosun University Medical School

5. Jeonnam Regional Cancer Center, Chonnam National University Hwasun Hospital

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/26/8/26_47167/_pdf

Reference50 articles.

1. 1) Mortality GBD and Causes of Death C: Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015; 385: 117-171

2. 2) In: Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health, ed by Fuster V and Kelly BB, Washington (DC), 2010

3. 3) Frostegard J: Immunity, atherosclerosis and cardiovascular disease. BMC Med, 2013; 11: 117

4. 4) Montagnana M, Lippi G, Salvagno GL, Franchini M, Targher G and Guidi GC: [Role of biochemical risk factors and markers for the risk of atherosclerosis]. Recenti progressi in medicina, 2008; 99: 215-222

5. 5) Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Jr., Taubert K, Tracy RP, Vinicor F, Centers for Disease C, Prevention and American Heart A: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003; 107: 499-511

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between blood Pentraxin‐3 concentrations and rheumatic diseases: A systematic review and meta‐analysis;European Journal of Clinical Investigation;2024-05-29

2. Sugar-Rich Food Intake Is Negatively Associated with Plasma Pentraxin 3 Levels;Journal of Obesity & Metabolic Syndrome;2023-11-13

3. Effect of Statins on the Inflammatory Markers in Patients with Coronary Artery Disease;Journal of Laboratory Physicians;2023-04-18

4. Association between major adverse cardiovascular events and pentraxin-3 in patients who have undergone coronary computed tomography angiography: from the FU-CCTA registry;Heart and Vessels;2022-09-28

5. Correlation between single nucleotide polymorphisms in the 3 primer untranslated region of PTX3 and the risk of essential hypertension;Medicine;2021-06-18